Medical Card
Get Your Medical Marijuana Card Today
Meet with a healthcare provider in minutes and receive the best care for the best value.
Get your medical card online in minutes!
Get startedExplore A-Z conditions
Medical Card
Meet with a healthcare provider in minutes and receive the best care for the best value.

Muscle spasms occur when nerve signals to a muscle become overactive or dysregulated — the muscle contracts but cannot release. This dysregulation often originates in the central nervous system, particularly in areas of the brain and spinal cord that are rich in cannabinoid (CB1) receptors.
When THC binds to CB1 receptors in the motor cortex, basal ganglia, cerebellum, and spinal cord, it dampens the overactive signalling that drives involuntary contractions. At the same time, CBD acts on CB2 receptors and several non-cannabinoid pathways to reduce the neuroinflammation that sensitises muscles and nerves in the first place. Together, they address two overlapping causes of spasms: hyperactive motor nerve firing and inflammatory sensitisation.
A 2016 study published in the Journal of Neurology, Neurosurgery & Psychiatry[1] found significant reductions in spasticity-related symptoms in MS patients using Sativex (a 1:1 THC:CBD oromucosal spray). A later review covering multiple trials concluded that more than half of patients with MS or spinal cord injuries reported clinically meaningful spasm relief — roughly 20% better than placebo across most trials.[2]
Tetrahydrocannabinol (THC) is the primary antispasmodic agent in cannabis. It:
Cannabidiol (CBD) does not directly relax muscles the way THC does, but it supports spasm relief through complementary mechanisms:
Terpenes in whole-plant cannabis products add further muscle-relaxing effects through the entourage effect:
| Terpene | Relevance for muscle spasms |
|---|---|
| Myrcene | Sedative and muscle-relaxant properties; synergises with THC to deepen physical relaxation |
| Beta-caryophyllene | CB2 agonist — directly reduces neuroinflammation and sensitised pain responses in spastic muscles |
| Linalool | Calming and anxiolytic; reduces stress-triggered spasms and nighttime spasticity flares |
| Limonene | Anti-inflammatory; may help with exercise-induced and injury-related muscle spasms during daytime use |
| Pinene | Bronchodilator and anti-inflammatory; may counteract short-term memory effects of THC at higher doses |
The right approach depends on whether your spasms are acute (sudden, intense contractions) or chronic (ongoing spasticity), and whether they are linked to a neurological condition or a more common cause like overuse or dehydration. Here’s how to think about it:
For neurological spasticity (MS, spinal cord injury, cerebral palsy)
A balanced 1:1 CBD:THC product — sublingual tincture or capsule — is the most clinically supported starting point, reflecting the formulation used in Sativex trials. The CBD component reduces neuroinflammation while THC directly dampens spastic signalling. Evening dosing is typically preferred, as sedative effects are useful for nighttime spasms and sleep disruption.
For acute or exercise-related spasms
A fast-acting vaporised product or sublingual tincture offers the quickest relief — onset within 1–5 minutes for vaporised, 15–30 minutes for sublingual. A topical balm or cream applied directly to the affected muscle can help with localised spasms without any systemic or psychoactive effects, and is a good option for daytime use.
For chronic pain alongside spasms
A higher-THC product with myrcene-rich terpenes, used in the evening, addresses both the pain and the spasm component simultaneously. Indica-leaning formulations are generally preferred for their body-heavy, sedating effects. Work with a medical cannabis physician to find a ratio that controls symptoms without excessive daytime impairment.
| Method | Onset / Duration / Best for |
|---|---|
| Sublingual (tincture/spray) | 15–30 min onset · 4–6 hrs · Best for consistent symptom control; mirrors the Sativex delivery route |
| Vaporised flower/concentrate | 1–5 min onset · 2–3 hrs · Best for acute spasm attacks; not recommended for lung-related conditions |
| Oral (capsules/edibles) | 30–90 min onset · 6–8 hrs · Best for overnight and sustained relief; not suitable for acute spasms |
| Topical (cream/balm) | 15–30 min local onset · No systemic effects · Best for localised spasms and daytime use without impairment |
| Transdermal patch | 1–2 hr onset · 8–12 hrs continuous · Good for chronic neurological spasticity requiring sustained dosing |
There is no universal dose for muscle spasms. Clinical trials for spasticity typically used low-to-moderate doses of THC (2.5–10 mg per dose). General guidance:
⚠ Drug interactions to be aware of
Cannabis can interact with several medications commonly used for spasticity and neurological conditions. Baclofen, tizanidine, benzodiazepines, and opioids all have CNS depressant effects that may be amplified by cannabis — particularly THC. CBD can also affect the metabolism of some anticonvulsants (e.g. clobazam) and immunosuppressants via the CYP450 pathway. Always disclose cannabis use to your prescribing physician before starting.
Yes — muscle spasms and spasticity are among the most widely recognised qualifying conditions for medical cannabis in the US. Most states list the condition either directly or through the underlying conditions that cause it:
| Condition | Qualifying status in MMJ states |
|---|---|
| Muscle spasms / spasticity | Directly listed in the majority of states with medical cannabis programs |
| Multiple sclerosis (MS) | Widely listed; spasticity is among the most documented cannabis-treatable MS symptoms |
| Spinal cord injury (SCI) | Listed in most states; spasm relief is one of the primary reasons SCI patients obtain MMJ cards |
| Cerebral palsy | Approved in many states; spasticity and movement disorders are core qualifying symptoms |
| Parkinson’s disease | Listed in a growing number of states; rigidity and tremor qualify in most programs |
| Chronic pain | Qualifies in every US medical state; covers spasm-related pain even if spasms alone are not listed |
| ALS | Qualifying condition in the majority of states; muscle stiffness and spasms are primary symptoms |
Leafwell’s licensed physicians can confirm your eligibility based on your specific state and diagnosis — typically in a same-day telehealth appointment. Even if your state does not explicitly list muscle spasms, the underlying condition or associated chronic pain almost always qualifies.
Muscle spasms are sudden, involuntary contractions of one or more muscles that last from a few seconds to several minutes. They range from the familiar cramp after exercise to the severe, painful contractions experienced by people with neurological conditions. Muscle spasticity is a related but distinct condition — a state of prolonged abnormal muscle tone and stiffness caused by damage to the central nervous system, affecting entire muscle groups rather than isolated contractions.
Around 12 million people worldwide live with clinically significant muscle spasticity, with MS and spinal cord injuries as the leading causes. For many, spasticity is not just uncomfortable — it disrupts sleep, limits mobility, and significantly reduces quality of life.
Depending on the cause and severity, symptoms may include:
Standard treatment depends on cause and severity:
Select your state from the drop down and we’ll let you know.